Enterprise Therapeutics

Enterprise Therapeutics

Enterprise Therapeutics

A UK-based developer of drugs to treat respiratory diseases
Founded
2014
Raised
$48.2M
Follow us
Alexa global traffic share
Latest funding Show all
£29,000,000
Venture capital (Series B) - 2018
Novartis Venture Fund Epidarex Capital Versant Ventures +2
Undisclosed amount
Venture capital - 2017
Cystic Fibrosis Trust
Team Size
2
Employees
£29,000,000 Venture capital (Series B)
PE HUB

Enterprise Therapeutics raises 29 mln pounds

Messaging
FinSMEs

Enterprise Therapeutics Raises £29M in Funding

Health Funding
Venture capital
Benzinga

Enterprise Therapeutics receives funding from Cystic Fibrosis Trust

£4,000,000 Venture capital
PE Hub , businesswire

Enterprise Therapeutics reels in $5 mln